Sleep-Related Eating Disorder: Parasomnia, Amnesia, Zolpidem and How It Differs From Night Eating

Bottom line: Sleep-related eating disorder (SRED) is not ordinary late-night snacking. It is a parasomnia in which eating or drinking happens after an arousal from sleep with impaired awareness and often partial or complete amnesia. The condition can create injury and poisoning risk, may coexist with other sleep disorders, and can be triggered or worsened by medications. Treatment starts with identifying those causes and making nighttime eating safer—not assuming the problem is simply willpower, hunger or an eating disorder.[1-9]

What sleep-related eating disorder looks like

SRED involves recurrent episodes of eating or drinking after an arousal from the main sleep period.[1-3,7]

Typical features can include:

• reduced awareness during the episode;
• partial or complete amnesia the next morning;
• compulsive or automatic eating;
• unusual food choices;
• eating combinations the person would not normally choose while fully awake;
• using kitchen equipment while only partially conscious;
• repeated episodes across many nights.[1-3,7]

The person may appear awake enough to walk, open cabinets, prepare food or speak.

That does not mean normal waking judgment is intact.

SRED is a parasomnia, not just nighttime overeating

The defining issue is the sleep-state disturbance.

Someone with SRED may be partly awake and partly asleep during the behavior.[2,3]

That places SRED closer to disorders of arousal such as sleepwalking than to ordinary waking overeating.

See Sleepwalking & NREM Parasomnias.

SRED and night eating syndrome are different

This is one of the most important distinctions.

Sleep-related eating disorder

SRED is characterized by parasomnia-like eating after sleep arousal with impaired awareness and often amnesia.[2,7-9]

Night eating syndrome

Night eating syndrome (NES) is more closely characterized by a delayed circadian pattern of food intake in which the person is awake and aware of the eating.[9]

Someone with NES may eat a large proportion of daily calories in the evening or wake deliberately to eat while remembering the episode.

Someone with SRED may discover evidence of eating the next morning without clear memory of doing it.

The overlap can be messy, but awareness and amnesia are major clues.

Amnesia is common—but not absolute

SRED commonly includes partial or complete amnesia.[2,3,5,7]

That does not mean every person remembers nothing.

Awareness can vary from episode to episode.

Some people have fragments of memory.

Others are told by a partner or infer episodes from food wrappers, dishes or missing food the next morning.

So “I remember part of it” does not automatically rule SRED out.

The safety risks are more important than the calories alone

The 2024 systematic review emphasizes potentially serious health consequences, including dangerous nighttime activities, weight gain and metabolic consequences.[1]

Reported risks can include:

• cutting injuries;
• burns;
• falls;
• leaving appliances on;
• eating raw or unsafe food;
• consuming inedible or toxic substances.[1,7]

That makes SRED a safety problem before it becomes a weight-management problem.

SRED can overlap with sleepwalking

Sleepwalking and SRED both involve incomplete arousal and complex behavior during sleep.[2,7,8]

Some experts view SRED as closely related to disorders of arousal.

The distinction is mainly what behavior dominates the episode: eating/drinking versus broader motor activity.

The two can coexist.

That is why someone with SRED may also need the same basic nighttime safety measures used for sleepwalking.

Restless legs and sleep apnea can matter

SRED frequently occurs alongside other sleep disorders.[2,7,8]

Associations include:

• restless legs syndrome;
• obstructive sleep apnea;
• sleepwalking;
• other causes of sleep fragmentation.[2,7,8]

The important clinical logic is:

A disorder that repeatedly fragments sleep can increase opportunities for abnormal partial arousals.

That does not mean OSA or RLS causes every SRED case.

But treating an untreated comorbid sleep disorder may reduce the arousal burden and can be more logical than adding another sedating medication.[2,8]

See Restless Legs, Iron and Sleep and Sleep Apnea vs Insomnia.

Zolpidem is one of the clearest medication associations

Medication-triggered SRED deserves special attention.

A 2020 literature review compiled 40 published zolpidem-associated SRED cases.[5]

In those reports:

• 65% were female;
• average age was 53;
• OSA was present in 35%;
• depression in 32.5%;
• RLS in 25%;
• all had partial or full amnesia for compulsive nighttime eating.[5]

Among cases with discontinuation information, stopping zolpidem resolved SRED in all 36 reported patients.[5]

That is a strong dechallenge signal.

But it is still case-report evidence, not a randomized causal trial.

Pharmacovigilance also flags multiple medications

A 2022 analysis of the WHO VigiBase pharmacovigilance database identified 676 reports of drug-associated SRED.[6]

Frequently reported drugs included:

• zolpidem;
• sodium oxybate;
• quetiapine;
• suvorexant; and
• several other psychotropic drugs.[6]

The reporting odds ratio for zolpidem was especially large in that database.[6]

This does not tell us true incidence or prove causality for every report.

Pharmacovigilance data are excellent for detecting safety signals and poor for estimating how often the event actually occurs among all users.

The practical lesson is simpler:

New sleep-eating behavior after starting or changing a psychoactive medication deserves medication review.

Do not stop prescribed medication abruptly from an article

Medication-associated SRED is a reason to contact the prescriber and reassess the medication plan.

It is not a reason for a website to tell every reader to abruptly discontinue a prescription.

The risks of withdrawal, rebound insomnia or recurrence of the treated condition depend on the medication and clinical context.

Polysomnography is not always required for diagnosis

The 2023 systematic review of PSG findings emphasizes that SRED is usually diagnosed from the clinical history and ICSD criteria; polysomnography is not required to confirm every case.[3]

That is important because the behavior may not occur during one laboratory night.

PSG can still be useful when clinicians need to:

• identify sleep apnea or another comorbid disorder;
• capture unusual nocturnal behavior;
• distinguish SRED from seizures or other parasomnias;
• clarify diagnostically confusing cases.[2,3]

So “normal sleep study” does not necessarily erase a convincing clinical SRED history.

The treatment literature is thin despite decades of reports

The 2024 systematic review retrieved 94 primary and secondary reports on SRED but concluded that high-quality epidemiologic studies and clinical trials remain scarce.[1]

That is a crucial calibration point.

Lots of publications do not automatically mean strong treatment evidence.

Much of the literature consists of:

• small series;
• case reports;
• retrospective observations;
• medication-trigger reports.[1]

Topiramate has randomized evidence—but the trial was small

The strongest direct drug evidence comes from a 2020 placebo-controlled randomized trial.[4]

Thirty-four adults with chronic SRED and at least three episodes per week were randomized for 13 weeks.[4]

Among evaluable participants:

• topiramate group: eating nights fell from 74.7% to 33.2%;
• placebo group: eating nights fell from 77.0% to 57.4%;
• between-group p = 0.035.[4]

Clinical Global Impression responders were:

• 71% with topiramate;
• 27% with placebo;
• p = 0.016.[4]

That is real randomized evidence.

But it is not the whole story.

Side effects and dropout matter

The topiramate trial was small and had a high dropout rate.[4]

Common adverse effects included:

• paresthesias;
• cognitive dysfunction.[4]

Participants taking topiramate also lost more weight than placebo participants.[4]

The correct conclusion is:

Topiramate has direct randomized evidence for SRED, but the evidence base is small and tolerability matters.

It is not:

“Topiramate is the universal treatment for sleep eating.”

Older medication recommendations need modern caution

Older reviews discuss SSRIs, clonazepam, dopaminergic therapy for RLS-associated cases and other drugs.[8]

Those recommendations come from a literature base that is much weaker and more heterogeneous than a modern guideline-level evidence set.

The 2024 systematic review specifically notes the shortage of high-quality trials.[1]

So medications should be described by evidence level and clinical context, not as a ranked consumer menu.

The first treatment question is often: what is driving the arousal?

The 2024 clinical review emphasizes that SRED commonly accompanies untreated sleep disorders or psychoactive medication exposure.[2]

That makes a practical hierarchy sensible:

1. identify and remove physical hazards;
2. review medications and substances;
3. assess for sleepwalking, RLS, OSA or other sleep fragmentation;
4. stabilize sleep opportunity and schedule;
5. consider targeted clinician-guided treatment for persistent idiopathic/refractory SRED.[1-3]

Weight loss is not the primary endpoint

SRED can contribute to excess calorie intake and weight gain.[1,4,7]

But treating the disorder as a diet problem misses the state-control issue.

A person cannot reliably apply ordinary appetite-control strategies to behavior occurring with impaired awareness or amnesia.

The first goal is to stop unsafe involuntary nighttime eating.

Metabolic and weight consequences matter, but they are downstream outcomes.

SRED is not a failure of willpower

This deserves explicit language.

A person with SRED may have little or no memory of the eating and reduced control during the partial arousal.

That is very different from deliberately deciding to eat late at night.

Shame-based advice is therefore both scientifically wrong and clinically unhelpful.

What the evidence does not show

Current evidence does not justify saying:

• all nighttime eating is SRED;
• SRED and night eating syndrome are the same;
• complete amnesia is required in every episode;
• zolpidem causes SRED in every user;
• pharmacovigilance reporting odds equal true incidence;
• everyone with SRED needs polysomnography;
• topiramate works for everyone;
• medication should be started or stopped without clinician review;
• weight loss is the main reason to treat SRED;
• supplements have an established role in SRED treatment.

Practical evidence hierarchy

For suspected SRED:

1. Establish the state. Is the eating deliberate and fully remembered, or does it occur in partial arousal with impaired awareness?
2. Make the environment safer. Reduce access to knives, hot appliances, toxic substances and dangerous foods during episodes.
3. Review medications. New parasomnia behavior after sedative-hypnotic or psychoactive medication changes is highly relevant.
4. Look for sleep fragmentation. OSA, RLS and sleepwalking may coexist.
5. Use PSG selectively. It can clarify competing sleep disorders or unusual events but is not mandatory for every classic presentation.
6. Use medication evidence proportionally. Topiramate has one small randomized trial; side effects and dropout prevent a universal recommendation.

Final verdict

Sleep-related eating disorder is a real parasomnia, not ordinary midnight snacking.

The combination of sleep arousal + impaired awareness + involuntary eating + partial or complete amnesia is the core pattern.

The biggest practical risks are injury, ingestion of unsafe substances, medication triggers and missed comorbid sleep disorders.

The strongest treatment logic is therefore cause-first: make the environment safer, review medications, identify sleep fragmentation and treat coexisting disorders. Topiramate has randomized evidence for persistent SRED, but the trial is small and adverse effects matter, so treatment remains clinician-guided rather than a self-treatment protocol.

Related reading

• Sleepwalking & NREM Parasomnias
• Night Terrors vs Nightmares
• Restless Legs, Iron and Sleep
• Sleep Apnea vs Insomnia
• Exploding Head Syndrome